Nantahala Capital Management, LLC 13D/13G Filings for Acer Therapeutics Inc. (ACER)

Nantahala Capital Management, LLC 13D and 13G filings for Acer Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-14
4:56 pm
Purchase
2022-12-31 13G Acer Therapeutics Inc.
ACER
Nantahala Capital Management, LLC 1,226,191
7.500%
324,901increase
(+36.05%)
Filing
2022-02-14
08:00 am
Sale
2021-12-31 13G Acer Therapeutics Inc.
ACER
Nantahala Capital Management, LLC 901,290
6.300%
-88,465decrease
(-8.94%)
Filing
2021-02-12
3:24 pm
Sale
2020-12-31 13G Acer Therapeutics Inc.
ACER
Nantahala Capital Management, LLC 989,755
8.100%
-900decrease
(-0.09%)
Filing